G-CON Manufacturing Inc.

article

Cleanroom infrastructure innovation to fulfil the needs of cell and gene therapies

26 April 2021 | By Maik W Jornitz

Biopharmaceuticals have transformed the patient care landscape, but alongside this step change in treatment capability comes the need for a similar paradigm shift in manufacturing capability. Here, Maik W Jornitz, President & CEO of G-CON Manufacturing Inc. highlights how cleanroom infrastructure must develop to keep pace with ever evolving industry needs.

article

G-CON: Spotlight on… Continuous Manufacturing

24 October 2018 | By G-Con

In this Spotlight on Continuous Manufacturing, G-Con explains how they have simplified the entire design/build/validate process via their prefabricated cleanroom infrastructure line...

article

Continuous Manufacturing Roundtable

23 October 2018 | By David Lovett (Perceptive Engineering Ltd), Dennis Powers - Vice President of Business Development & Sales Engineering G-CON Manufacturing Inc., Jan Verelst - Global Business Development Manager for SIPAT at Siemens, Marco Bellentani Product Manager for Containment and Innovative Solutions at MG2, Massimo Bresciani - R&D Executive Director for Business Development & Scientific Operation at RCPE, Richard Steiner - Business Development Manager for continuous oral solid dosage (OSD) systems at GEA

Welcome to European Pharmaceutical Review’s roundtable devoted to continuous manufacturing. We have brought together six industry experts to focus on how the contribution of continuous manufacturing technology is shaping the pharmaceutical sector and explain what factors are driving that change.